1. Home
  2. NUTX vs GNFT Comparison

NUTX vs GNFT Comparison

Compare NUTX & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUTX
  • GNFT
  • Stock Information
  • Founded
  • NUTX 2011
  • GNFT 1999
  • Country
  • NUTX United States
  • GNFT France
  • Employees
  • NUTX N/A
  • GNFT N/A
  • Industry
  • NUTX Retail: Computer Software & Peripheral Equipment
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NUTX Technology
  • GNFT Health Care
  • Exchange
  • NUTX Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • NUTX 182.2M
  • GNFT 172.2M
  • IPO Year
  • NUTX N/A
  • GNFT 2019
  • Fundamental
  • Price
  • NUTX $37.81
  • GNFT $3.47
  • Analyst Decision
  • NUTX Strong Buy
  • GNFT Strong Buy
  • Analyst Count
  • NUTX 2
  • GNFT 1
  • Target Price
  • NUTX $55.00
  • GNFT $13.00
  • AVG Volume (30 Days)
  • NUTX 25.0K
  • GNFT 6.9K
  • Earning Date
  • NUTX 11-07-2024
  • GNFT 09-19-2024
  • Dividend Yield
  • NUTX N/A
  • GNFT N/A
  • EPS Growth
  • NUTX N/A
  • GNFT N/A
  • EPS
  • NUTX N/A
  • GNFT 0.47
  • Revenue
  • NUTX $292,000,390.00
  • GNFT $86,225,222.00
  • Revenue This Year
  • NUTX $25.00
  • GNFT $145.20
  • Revenue Next Year
  • NUTX $14.40
  • GNFT N/A
  • P/E Ratio
  • NUTX N/A
  • GNFT $7.23
  • Revenue Growth
  • NUTX 26.02
  • GNFT 175.45
  • 52 Week Low
  • NUTX $4.16
  • GNFT $3.33
  • 52 Week High
  • NUTX $41.44
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • NUTX 63.48
  • GNFT 31.89
  • Support Level
  • NUTX $28.82
  • GNFT $3.35
  • Resistance Level
  • NUTX $35.94
  • GNFT $3.57
  • Average True Range (ATR)
  • NUTX 2.18
  • GNFT 0.11
  • MACD
  • NUTX 0.47
  • GNFT 0.01
  • Stochastic Oscillator
  • NUTX 77.57
  • GNFT 21.82

About NUTX Nutex Health Inc.

Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: